Extended-Release Drugs Market 2024 industry trends, sales, demand, analysis & forecasts to 2024; key players - Pfizer, Mallinckrodt, Lupin Limited, Actavis, Janssen Pharmaceuticals, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd.
As per the research conducted by Fast. MR, the report titled “ Extended-Release Drugs Market By Dosage Form (Tablet, Capsule and Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Global Market Size, Development, Growth and Demand Forecast, 2014-2024 ” provides current as well as future analysis of the market by evaluating the major applications, advantages, trends, and challenges. The report dives deeper to produce useful insights into Extended-Release Drugs Market such as major global regions and key competitors and strategies that can be used for the entry-level player too. Overview Extended-release drugs offer some potential advantages over other medicines, as it reduces the frequency of dosing by modifying the rate of drug absorption. Thus, extended-release drugs enable higher doses to be given less frequently with less fluctuation in blood